Skip to main content
Top
Published in: Pediatric Cardiology 5/2015

01-06-2015 | Case Report

Absence of Family History and Phenotype–Genotype Correlation in Pediatric Brugada Syndrome: More Burden to Bear in Clinical and Genetic Diagnosis

Authors: Houria Daimi, Amel Haj Khelil, Khaldoun Ben Hamda, Amelia Aranega, Jemni B. E. Chibani, Diego Franco

Published in: Pediatric Cardiology | Issue 5/2015

Login to get access

Abstract

Brugada syndrome (BrS) is an autosomal-dominant genetic cardiac disorder caused in 18–30 % of the cases by SCN5A gene mutations and manifested by an atypical right bundle block pattern with ST segment elevation and T wave inversion in the right precordial leads. The syndrome is usually detected after puberty. The identification of BrS in pediatric patients is thus a rare occurrence, and most of the reported cases are unmasked after febrile episodes. Usually, having a family history of sudden death represents the first reason to perform an ECG in febrile children. However, this practice makes the sporadic cases of cardiac disease and specially the asymptomatic ones excluded from this diagnosis. Here, we report a sporadic case of a 2-month-old male patient presented with vaccination-related fever and ventricular tachycardia associated with short breathing, palpitation and cold sweating. ECG changes were consistent with type 1 BrS. SCN5A gene analysis of the proband and his family revealed a set of mutations and polymorphisms differentially distributed among family members, however, without any clear genotype–phenotype correlation. Based on our findings, we think that genetic testing should be pursued as a routine practice in symptomatic and asymptomatic pediatric cases of BrS, with or without family history of sudden cardiac death. Similarly, our study suggests that pediatrician should be encouraged to perform an ECG profiling in suspicious febrile children and quickly manage fever since it is the most important factor unmasking BrS in children.
Literature
1.
go back to reference An RH, Wang XL, Kerem B, Benhorin J, Medina A, Goldmit M, Kass RS (1998) Novel LQT-3 mutation affects Na+ channel activity through interactions between α-and β1-subunits. Circ Res 83:141–146CrossRefPubMed An RH, Wang XL, Kerem B, Benhorin J, Medina A, Goldmit M, Kass RS (1998) Novel LQT-3 mutation affects Na+ channel activity through interactions between α-and β1-subunits. Circ Res 83:141–146CrossRefPubMed
2.
go back to reference Brugada P, Brugada J (1992) Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20:1391–1396CrossRefPubMed Brugada P, Brugada J (1992) Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20:1391–1396CrossRefPubMed
3.
go back to reference Chockalingam P, Clur SAB, Breur JMPJ, Kriebel T, Paul T, Rammeloo LA, Wilde AAM, Blom NA (2012) The diagnostic and therapeutic aspects of loss-of-function cardiac sodium channelopathies in children. Heart Rhythm 9(12):1986–1992CrossRefPubMed Chockalingam P, Clur SAB, Breur JMPJ, Kriebel T, Paul T, Rammeloo LA, Wilde AAM, Blom NA (2012) The diagnostic and therapeutic aspects of loss-of-function cardiac sodium channelopathies in children. Heart Rhythm 9(12):1986–1992CrossRefPubMed
4.
go back to reference Cummings S, Priori S (2011) Genetics of cardiac arrhythmias. Minerva Med 102:209–222PubMed Cummings S, Priori S (2011) Genetics of cardiac arrhythmias. Minerva Med 102:209–222PubMed
5.
go back to reference Makita N, Seki A, Sumitomo N, Chkourko H, Fukuhara S, Watanabe H, Shimizu W, Bezzina CR, Hasdemir C, Mugishima H, Makiyama T, Baruteau A, Baron E, Horie M, Hagiwara N, Wilde AAM, Probst V, Le Marec H, Roden DM, Mochizuki N, Schott JJ, Delmar M (2012) A connexin40 mutation associated with a malignant variant of progressive familial heart block type I. Circ Arrhythm Electrophysiol 5:163–172CrossRefPubMedCentralPubMed Makita N, Seki A, Sumitomo N, Chkourko H, Fukuhara S, Watanabe H, Shimizu W, Bezzina CR, Hasdemir C, Mugishima H, Makiyama T, Baruteau A, Baron E, Horie M, Hagiwara N, Wilde AAM, Probst V, Le Marec H, Roden DM, Mochizuki N, Schott JJ, Delmar M (2012) A connexin40 mutation associated with a malignant variant of progressive familial heart block type I. Circ Arrhythm Electrophysiol 5:163–172CrossRefPubMedCentralPubMed
6.
go back to reference Millat G, Chevalier P, Restier-Miron L, Da Costa A, Bouvagnet P, Kugener B, Fayol L, Gonzàlez Armengod C, Oddou B, Chanavat V, Froidefond E, Perraudin R, Rousson R, Rodriguez-Lafrasse C (2006) Spectrum of pathogenic mutations and associated polymorphisms in a cohort of 44 unrelated patients with long QT syndrome. Clin Genet 70:214–227CrossRefPubMed Millat G, Chevalier P, Restier-Miron L, Da Costa A, Bouvagnet P, Kugener B, Fayol L, Gonzàlez Armengod C, Oddou B, Chanavat V, Froidefond E, Perraudin R, Rousson R, Rodriguez-Lafrasse C (2006) Spectrum of pathogenic mutations and associated polymorphisms in a cohort of 44 unrelated patients with long QT syndrome. Clin Genet 70:214–227CrossRefPubMed
7.
go back to reference Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U, Bloise R, Giustetto C, De Nardis R, Grillo M, Ronchetti E, Faggiano G, Nastoli J (2002) Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 105:1342–1347CrossRefPubMed Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U, Bloise R, Giustetto C, De Nardis R, Grillo M, Ronchetti E, Faggiano G, Nastoli J (2002) Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 105:1342–1347CrossRefPubMed
8.
go back to reference Probst V, Wilde AA, Barc J et al (2009) SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Circ Cardiovasc Genet 2:552–557CrossRefPubMed Probst V, Wilde AA, Barc J et al (2009) SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Circ Cardiovasc Genet 2:552–557CrossRefPubMed
9.
10.
go back to reference Rook MB, Bezzina CA, Groenewegen WA, Gelder IC, van Ginneken AGC, Jongsma HJ, Mannens MMMA, Wilde AAM (1999) Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome. Cardiovasc Res 44:507–517CrossRefPubMed Rook MB, Bezzina CA, Groenewegen WA, Gelder IC, van Ginneken AGC, Jongsma HJ, Mannens MMMA, Wilde AAM (1999) Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome. Cardiovasc Res 44:507–517CrossRefPubMed
Metadata
Title
Absence of Family History and Phenotype–Genotype Correlation in Pediatric Brugada Syndrome: More Burden to Bear in Clinical and Genetic Diagnosis
Authors
Houria Daimi
Amel Haj Khelil
Khaldoun Ben Hamda
Amelia Aranega
Jemni B. E. Chibani
Diego Franco
Publication date
01-06-2015
Publisher
Springer US
Published in
Pediatric Cardiology / Issue 5/2015
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-015-1133-5

Other articles of this Issue 5/2015

Pediatric Cardiology 5/2015 Go to the issue